Allergy Shot Market (2024 - 2034)
Allergy Shot Market Study by SLIT Tablets, Oral, and Injections for Allergic Rhinitis, Allergic Asthma, Food Allergy, and Atopic Dermatitis from 2024 to 2034
Core Findings
FREE CustomizationAllergy Shot Market Outlook (2024 to 2034)
The global allergy shot market is expected to reach a valuation of US$ 1.84 billion in 2024 and further expand at a CAGR of 6.1% to end up at US$ 3.34 billion by 2034.
An allergy occurs when the body's immune system reacts too strongly to an exogenous item, such as food, pollen, fur, or dust. During allergy immunotherapy, the body is exposed to small amounts of allergens to stimulate the production of antibodies against them. This therapy is an efficient method to treat allergies by regularly exposing the body to specific allergens in low doses.
- The World Allergy Organization estimates that currently, 10 to 30 percent of people worldwide suffer from some form of allergy.
Factors such as population growth, industrialization, advancements in healthcare and medicine, and the introduction of new immunotherapeutic treatments are driving the global market for allergy immunotherapy. Recent regulatory approvals, including those for oral dissolvable tablets, are also expected to further expand the market for allergy shots.
Allergy symptoms can range from mild, such as hives or a rash, to more severe symptoms like itching, a runny nose, and watery or red eyes. Treatment options for allergies vary depending on the specific allergen sensitivity of the patient. Over-the-counter medications are available for mild allergies, with antihistamines being commonly used. Decongestants provide short-term relief.
For skin reactions like redness and irritation due to allergies, creams, and lotions are often used. Inflammation caused by an allergic reaction can be reduced with steroid treatments. Natural remedies, over-the-counter pharmaceuticals, and prescription medications are also options for managing seasonal allergies.
Allergy shots decrease sensitivity to allergens. In individuals with allergies, the immune system can overreact to harmless substances. Common triggers include dust mites, mold, pollen, pet dander, and insect venom. Allergy shots expose the body to small, safe doses of these triggers, similar to vaccination, which helps the immune system build tolerance and reduce allergy symptoms over time.
The benefits of allergy shots include better allergy management, reduced long-term treatment needs, and decreased sensitivity to various allergens. These advantages are expected to drive increased demand for allergy shots, contributing to the expansion of the allergy shot market size in the foreseeable future.
| Report Attribute | Detail |
|---|---|
| Allergy Shot Market Size (2024E) | US$ 1.84 Billion |
| Forecasted Market Value (2034F) | US$ 3.34 Billion |
| Global Market Growth Rate (2024 to 2034) | 6.1% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 6.4% CAGR |
| China Market Value (2034F) | US$ 454 Million |
| North America Market Share (2024E) | 39% |
| East Asia Market Share (2034F) | 23.2% |
| Key Companies Profiled | Circassia; Merck; Allergy Therapeutics; ALK-Abello; Letipharma; HollisterStier Allergy; Aimmune Therapeutics; DBV Technologies; Stallergenes Greer; HAL Allergy Group; Biomay AG. |
Why is Demand for Allergy Shots on the Rise Worldwide?
“Increasing Prevalence of Rhinitis Necessitating More Effective Treatments”
- In 2022, research published in Clinical and Translational Allergy indicated that the global median prevalence rates for NAR, AR, and nonspecific rhinitis were 18.1%, 12.0%, and 29.4%, respectively, with variations observed across different regions.
- According to the Centers for Disease Control and Prevention's estimates for 2023, approximately 25.7% of American adults aged 18 and over were expected to experience seasonal allergies, encompassing nearly 31.8% of the adult population.
This trend is being mirrored in other countries worldwide, contributing to allergy shot market growth. Over time, the prevalence of rhinitis continues to increase, driven by a rise in allergic conditions and a growing necessity for more effective treatments. This growing market for allergy injections is also influenced by urbanization and changing lifestyles, which contribute to the emergence of new allergic conditions.
Factors such as pollution levels, unhealthy dietary habits, and alcohol consumption can trigger various allergic responses, including food and skin allergies, thereby potentially boosting the demand for allergy shot therapies.
The market for allergy shots remains dynamic, driven by advancements in recombinant immunotherapies, specialized medications, and other factors. Industry players are continually expanding their product portfolios, customer bases, and global presence through strategies like mergers, acquisitions, partnerships, and collaborative initiatives. These efforts enable them to meet evolving customer needs, maintain competitiveness, and foster collective growth.
- For instance, Nestle Health Science announced in August 2020 its acquisition of Immune Therapeutics' food allergy product line, exemplifying strategic moves aimed at enhancing its market position and addressing growing demands in allergy treatment.
What are the Key Concerns in the Market for Allergy Shots?
“Lengthy Treatment Times Not Favored by Many”
Allergy shots require a lengthy course, typically lasting three to five years, tailored to the allergy type and severity. Many patients discontinue due to treatment duration, age, health, location, and financial constraints, hindering industry growth. Furthermore, the market size is shrinking due to the adverse effects of allergy pills and injections.
- For instance, a 2022 study published in Human Vaccines & Immunotherapeutics reported that over 10% of patients experienced adverse reactions, including mild to severe local symptoms like oral pruritus (25%), throat discomfort (21%), and mild systemic effects like edema or redness at injection sites.
“High Cost of Treatment Coupled with Poor Patient Adherence”
Allergy shots provide numerous benefits, yet patient adherence to treatment is often insufficient due to factors such as limited patient awareness and inadequate funding.
- For instance, a 2022 NCBI paper highlights that discomfort associated with subcutaneous (SCIT) and sublingual treatments, along with side effects, are primary reasons for treatment discontinuation.
High cost of treatment and lack of insurance coverage in some countries are expected to restrict the accessibility of allergy shots.
Country-wise Insights
The market in South Korea is forecasted to expand at a CAGR of 6.2% from 2024 to 2034. The country is set to hold 25.2% of the East Asia allergy shot market share by the end of 2034.
What Makes the United States an Attractive Market for Allergy Shot Manufacturers?
“Advanced Clinical Trials and Huge Investments by Corporates”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 605 Million |
| Growth Rate (2024 to 2034) | 6.5% CAGR |
| Projected Value (2034F) | US$ 1.14 Billion |
Firms in the United States are increasing their spending on developing cutting-edge products that are user-friendly and offer quick results. This is one of the key allergy shot market trends in the country.
- Moonlight Therapeutics, Inc., a biotechnology company investigating therapeutics for food allergies, reported in 2021 that it had received US$ 1.9 million in investment for preclinical studies and product development. This was done to get ready for a clinical trial for the company's principal program in peanut allergy. This financing was made possible by a Phase 2 Small Business grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).
Why are Market Players Flocking China for Future Business Prospects?
“Government Reforms Supporting Access to Quality Healthcare”
| Attribute | China |
|---|---|
| Segment Value (2024E) | US$ 217 Million |
| Growth Rate (2024 to 2034) | 7.6%CAGR |
| Projected Value (2034F) | US$ 454 Million |
China's population is experiencing a significant increase in allergic conditions, driven by urbanization, changing lifestyles, and environmental factors. This rising prevalence of allergies creates a growing demand for effective treatments like allergy shots. The Chinese government has formulated healthcare reforms to enhance access to quality medical services across the country. This supportive regulatory environment encourages market players to invest in innovative allergy treatments
Category-wise Evaluation
Based on product type, sales of odactra are forecast to rise at a CAGR of 5.4% from 2024 to 2034.
Which Type of Immunotherapy Has Gained Prominence in the Market?
“Growing Demand for Subcutaneous Immunotherapy”
| Attribute | Subcutaneous Immunotherapy |
|---|---|
| Segment Value (2024E) | US$ 952 Million |
| Growth Rate (2024 to 2034) | 6.1% CAGR |
| Projected Value (2034F) | US$ 1.72 Billion |
Allergen-specific subcutaneous immunotherapy effectively treats various allergy disorders. The optimal injection site is the mid-posterolateral region of the upper arm. Subcutaneous immunotherapy (SCIT) represents an innovative approach to managing allergic conditions by modifying the underlying immunological mechanisms, thereby reducing symptoms. Its effectiveness and safety in treating stinging insect hypersensitivity, asthma, and allergic rhinitis/rhino-conjunctivitis have been validated in numerous controlled clinical studies.
What is the Main Reason Behind Global Increase in Allergic Rhinitis Cases?
“Rise in Urbanization and Environmental Pollutants”
| Attribute | Allergic Rhinitis |
|---|---|
| Segment Value (2024E) | US$ 784 Million |
| Growth Rate (2024 to 2034) | 6% CAGR |
| Projected Value (2034F) | US$ 1.41 Billion |
Allergy, also referred to as hay fever or allergic rhinitis, is primarily driven by the global increase in allergic rhinitis cases.
- According to a 2022 article in Frontiers of Medicine, approximately 400 million people worldwide suffer from allergic rhinitis (AR), making it a significant global health concern.
The prevalence of AR has risen alongside increasing urbanization and environmental pollutants, which are major contributing factors to this condition's growth over time.
Competitive Landscape
Through expansion, collaborations, new product development, mergers and acquisitions, and other growth tactics, key players in the allergy shot market are adapting themselves to the evolving market trends.
- In October 2023, Itulatek's phase 3 experiment for the treatment of allergic rhino-conjunctivitis brought on by tree pollen was completed, according to ALK.
- In January 2023, HollisterStier Allergy introduced Ultrafiltered Dog, their newest product innovation, to the allergy market. Patients who are sensitive to dogs respond well to the product's diagnosis and therapy.
- In October 2022, Aimmune Therapeutics and Allergy Partners, a specialized allergy practice group, partnered to provide Palforzia, an oral immunotherapy, to patients directly.
Fact.MR provides detailed information about the price points of key allergy shot manufacturers positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.
Key Segments of Allergy Shot Market Research
-
By Product :
- SLIT Tablets
- Odactra
- Grastek
- Ragwitek
- Oralair
- Actair
- Others
- Oral
- Palforzia
- Others
- Injections
- Others
- SLIT Tablets
-
By Immunotherapy :
- Sublingual Immunotherapy (SLIT)
- Subcutaneous Immunotherapy (SCIT)
- Specific Immunotherapy
- Others
-
By Indication :
- Allergy Rhinitis
- Allergic Asthma
- Food Allergy
- Atopic Dermatitis
- Others
-
By Allergen :
- Pollen
- Grass Pollen
- Weed Pollen
- Tree Pollen
- House Dust Mites (HDMs)
- Mold
- Animal Dander
- Bee Venom
- Cockroaches/Insects
- Others
- Pollen
-
By Distribution Channel :
- Institutional Sales
- Government Hospitals
- Semi-Government Hospitals
- Private Hospitals
- Retail Sales
- Retail Pharmacy
- Drug Stores
- Online Pharmacy
- Institutional Sales
-
By Region :
- North America
- Latin America
- Eastern Europe
- Western Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Immunotherapy
- 6.2. Product
- 6.3. Indication
- 6.4. Allergen
- 6.5. Distribution Channel
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Immunotherapy
- 7.1. Sublingual Immunotherapy (SLIT)
- 7.2. Subcutaneous Immunotherapy (SCIT)
- 7.3. Specific Immunotherapy
- 7.4. Others
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
- 8.1. SLIT Tablets
- 8.2. Oral
- 8.3. Injections
- 8.4. Others
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Indication
- 9.1. Allergy Rhinitis
- 9.2. Allergic Asthma
- 9.3. Food Allergy
- 9.4. Atopic Dermatitis
- 9.5. Others
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Allergen
- 10.1. Pollen
- 10.2. House Dust Mites (HDMs)
- 10.3. Mold
- 10.4. Animal Dander
- 10.5. Bee Venom
- 10.6. Cockroaches/Insects
- 10.7. Others
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 11.1. Institutional Sales
- 11.2. Retail Sales
- 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Western Europe
- 12.4. Eastern Europe
- 12.5. East Asia
- 12.6. South Asia & Pacific
- 12.7. Middle East & Africa
- 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 20. Sales Forecast 2024 to 2034 by Immunotherapy, Product, Indication, Allergen, Distribution Channel, and Region for 30 Countries
- 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 22. Company Profile
- 22.1. Circassia
- 22.2. Merck
- 22.3. Allergy Therapeutics
- 22.4. ALK-Abello
- 22.5. Letipharma
- 22.6. HollisterStier Allergy
- 22.7. Aimmune Therapeutics
- 22.8. DBV Technologies
- 22.9. Stallergenes Greer
- 22.10. HAL Allergy Group
- 22.11. Biomay AG
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 16: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 17: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 31: North America Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 32: North America Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 34: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 35: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 46: Latin America Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 47: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 49: Latin America Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 50: Latin America Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 52: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 53: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 61: Western Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 62: Western Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 63: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 64: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 65: Western Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 67: Western Europe Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 68: Western Europe Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 70: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 71: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: Eastern Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 77: Eastern Europe Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 78: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 79: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 80: Eastern Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 81: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 82: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 83: Eastern Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 84: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 91: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: East Asia Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 95: East Asia Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 96: East Asia Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 97: East Asia Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 98: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 99: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 100: East Asia Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 101: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 102: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 103: East Asia Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 104: East Asia Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 105: East Asia Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 106: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 107: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 109: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 110: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 111: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 112: South Asia & Pacific Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 113: South Asia & Pacific Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 114: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 115: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 116: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 117: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 118: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 119: South Asia & Pacific Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 120: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 121: South Asia & Pacific Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 122: South Asia & Pacific Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 123: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 124: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 125: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 126: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 127: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 128: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 129: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 130: MEA Market Value (US$ Mn) Analysis, by Immunotherapy, 2019 to 2023
Table 131: MEA Market Value (US$ Mn) Analysis, by Immunotherapy, 2024 to 2034
Table 132: MEA Market Value (US$ Mn) Opportunity Analysis, by Immunotherapy, 2024 to 2034
Table 133: MEA Market Value (US$ Mn) Analysis, by Product, 2019 to 2023
Table 134: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 135: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 136: MEA Market Value (US$ Mn) Analysis, by Indication, 2019 to 2023
Table 137: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 138: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 139: MEA Market Value (US$ Mn) Analysis, by Allergen, 2019 to 2023
Table 140: MEA Market Value (US$ Mn) Analysis, by Allergen, 2024 to 2034
Table 141: MEA Market Value (US$ Mn) Opportunity Analysis, by Allergen, 2024 to 2034
Table 142: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 143: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 144: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 20: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 21: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 22: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 23: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 24: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 25: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 26: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 27: North America Market Share Analysis by Country, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 39: North America Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 40: North America Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 41: North America Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 42: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 43: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 44: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 45: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 46: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 47: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 48: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 49: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 58: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 59: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 60: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 61: Latin America Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 62: Latin America Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 63: Latin America Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 64: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 65: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 66: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 67: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 68: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 69: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 70: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 71: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 77: Western Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 78: Western Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 79: Western Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 80: Western Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 81: Western Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 83: Western Europe Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 84: Western Europe Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 85: Western Europe Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 86: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 87: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 88: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 89: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 90: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 91: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 92: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 93: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 96: Eastern Europe Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 97: Eastern Europe Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 99: Eastern Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 100: Eastern Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 101: Eastern Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 102: Eastern Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 103: Eastern Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 104: Eastern Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 105: Eastern Europe Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 106: Eastern Europe Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 107: Eastern Europe Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 108: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 110: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 111: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 112: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 113: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 114: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 115: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 116: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 117: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 118: East Asia Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 119: East Asia Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 120: East Asia Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 121: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 122: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 123: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 124: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 125: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 126: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 127: East Asia Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 128: East Asia Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 129: East Asia Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 130: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 131: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 132: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 133: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 134: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 135: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 136: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 137: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 138: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 139: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 140: South Asia & Pacific Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 141: South Asia & Pacific Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 142: South Asia & Pacific Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 143: South Asia & Pacific Market Share and BPS Analysis by Product, 2024 & 2034
Figure 144: South Asia & Pacific Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 145: South Asia & Pacific Market Attractiveness Analysis by Product, 2024 to 2034
Figure 146: South Asia & Pacific Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 147: South Asia & Pacific Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 148: South Asia & Pacific Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 149: South Asia & Pacific Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 150: South Asia & Pacific Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 151: South Asia & Pacific Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 152: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 153: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 154: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 155: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 156: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 157: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 158: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 159: MEA Market Share Analysis by Country, 2024 & 2034
Figure 160: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 161: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 162: MEA Market Share and BPS Analysis by Immunotherapy, 2024 & 2034
Figure 163: MEA Market Y-o-Y Growth Projections by Immunotherapy, 2024 to 2034
Figure 164: MEA Market Attractiveness Analysis by Immunotherapy, 2024 to 2034
Figure 165: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 166: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 167: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 168: MEA Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 169: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 170: MEA Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 171: MEA Market Share and BPS Analysis by Allergen, 2024 & 2034
Figure 172: MEA Market Y-o-Y Growth Projections by Allergen, 2024 to 2034
Figure 173: MEA Market Attractiveness Analysis by Allergen, 2024 to 2034
Figure 174: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 175: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 176: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
- FAQs -
How big is the allergy shot market in 2024?
The global market for allergen shots is estimated at US$ 1.84 billion in 2024.
What is the demand outlook for allergy shots by 2034?
Global sales for allergy shots are forecasted to reach US$ 3.34 billion by 2034.
At what rate are the sales for allergy shots projected to rise?
The allergy shot market is forecasted to expand at a CAGR of 6.1% from 2024 to 2034.
How much share of global market revenue is North America evaluated to hold?
North America is forecasted to hold 40.3% share of the global market by 2034.
At what CAGR is the demand for allergy shots evaluated to accelerate in Japan?
The market in Japan is projected to increase at 5.6% CAGR from 2024 to 2034.
What is the contribution of subcutaneous immunotherapy to global market revenue?
The subcutaneous immunotherapy segment is projected to account for 51.7% share of global market revenue by 2034.
Who are the prominent manufacturers of allergy shots?
Some of the leading market players are Circassia, Merck, Allergy Therapeutics, and ALK-Abello.
Related Reports
Allergy Shot Market